A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

NCT00992225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: LY573636-sodium

Sponsor

Eli Lilly and Company